{
    "code": 0,
    "data": [
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results As On 30 Th Septemer 2025",
            "news_body": "Results as on 30.09.2025",
            "news_id": "57be02f5-a926-4dbc-a183-7c19d77f6032",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc6fe8d9-f426-4dcc-a154-c1593e180673.pdf",
            "news_date": "2025-11-14 17:27:50",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On June 30 2025",
            "news_body": "Financials results as on June 30 2025",
            "news_id": "ed823dd0-a39d-4a20-bcb2-3b2d832da42f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf191b89-8331-4f61-87c1-c7b5527f3341.pdf",
            "news_date": "2025-08-13 17:57:51",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, we would like to inform you that the Board of Director in their Meeting Held Today which was Commenced at 3.00 PM and Concluded at 05.15 P.M.",
            "news_id": "ae0e59f6-a728-400f-af07-48313b2f1e9c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e430f48-35fe-46f1-b976-97ee05db2cfb.pdf",
            "news_date": "2023-11-10 17:35:22",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. June 09, 2023",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 12.00 p.m. and concluded at 04.30 p.m 1. The Audited Financial Results of the Company for the Quarter and financial Year ended      March 31, 2023 <BR>",
            "news_id": "6cc14e07-7442-4d98-9008-70c6a63ade68",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f3f8fdf-1f03-42db-a7ec-b7134e7238ab.pdf",
            "news_date": "2023-06-09 16:46:07",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E.  February 14, 2023",
            "news_body": "we would like to inform you that the Board of Directors in their meeting held today which was commenced at 3.30 p.m. and concluded at 5.00 p.m. inter- alia have considered and approved the following: <BR> 1. The statement of unaudited Financial Results of the Company for the quarter ended on December 31, 2022.<BR> <BR> 2. Limited Review Report from Statutory Auditor for the quarter ended on December 31, 2022.",
            "news_id": "647fb5b3-fa3c-4e93-a83e-8ab46a560fdd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03bb9720-7d7f-4a4a-af4b-68272783e375.pdf",
            "news_date": "2023-02-14 17:20:19",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. November 14, 2022",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 p.m. and concluded at 3.30 p.m. inter- alia have considered and approved the following: <BR> 1. The statement of unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2022.<BR> 2. Limited Review Report from Statutory Auditor for the quarter and half year ended on September 30, 2022.  <BR>",
            "news_id": "87474bce-784f-46eb-ab46-433996be7151",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e9d5e94-446d-4290-a337-4ddfd17ec561.pdf",
            "news_date": "2022-11-14 15:38:22",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. August 08, 2022",
            "news_body": "considered and approved the following:<BR> 1. The statement of unaudited Financial Results of the Company for the Quarter Ended on June 30,<BR> 2022.<BR> 2. Limited Review Report from Statutory Auditor for the quarter ended on June 30, 2022.<BR> 3. Re appointment of Ms. Manali Bhagtani (DIN: 08067867) as an Independent Director of the<BR> Company for the second term of 5 years. The brief profile of the Independent Director is enclosed<BR> as Annexure-I.",
            "news_id": "7c2649ea-59e7-4993-b3b1-2d0208c7354e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c6f8038-ace6-4b96-ab5c-a7edc860dece.pdf",
            "news_date": "2022-08-08 15:13:54",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For Year Ended March 31, 2022",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations,<BR> 2015, we would like to inform you that the Board of Directors in their meeting held today which was<BR> commenced at 10.30 a.m. and concluded at 12:45 p.m. inter- alia have considered and approved the<BR> following:<BR> 1. The Audited Financial Results of the Company for the Quarter and financial Year ended<BR> March 31, 2022.<BR> 2. Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year<BR> ended March 31, 2022, subject to the approval of the shareholders at the ensuing General Meeting<BR> of the Company.<BR>",
            "news_id": "cf4bf1f6-b09d-4e18-a616-dfbbd1bb1ee5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b9e7ae8-1237-40af-9a93-27f3e3f29ca3.pdf",
            "news_date": "2022-04-11 13:17:35",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for  Outcome Of Board Meeting Held Today I.E. April 11, 2022",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations,<BR> 2015, we would like to inform you that the Board of Directors in their meeting held today which was<BR> commenced at 10.30 a.m. and concluded at 12:45 p.m. inter- alia have considered and approved the<BR> following:<BR> 1. The Audited Financial Results of the Company for the Quarter and financial Year ended<BR> March 31, 2022.<BR> 2. Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year<BR> ended March 31, 2022, subject to the approval of the shareholders at the ensuing General Meeting<BR> of the Company.",
            "news_id": "92a0fcdd-dbc0-40d8-9806-7e07182718d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb28da2e-be2b-4340-93f4-cb820d46b8c4.pdf",
            "news_date": "2022-04-11 13:01:10",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. February 07, 2022",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements)<BR> Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held<BR> today which commenced at 02.00 p.m. and concluded at 3.30 p.m. inter- alia has considered and<BR> approved the following:<BR> 1. The statement of un-audited financial result for the quarter and nine months ended December<BR> 31, 2021.<BR> 2. Limited review Report from Statutory Auditor for the quarter ended December 31, 2021.",
            "news_id": "31f8df8b-c7f8-4de4-be95-269ce880a267",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0503124a-f482-4686-bd77-b263a1577265.pdf",
            "news_date": "2022-02-07 15:41:47",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. November 14, 2021",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 12:00 Noon and concluded at 02:10 p.m. inter- alia has considered and approved",
            "news_id": "a2cdb5f9-d2fb-48e4-9ccc-f8ab87ba9ee0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19e9935a-5cb9-484b-ae27-9fd4372b5e2f.pdf",
            "news_date": "2021-11-14 14:18:22",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations,<BR> 2015, we would like to inform you that the Board of Directors in their meeting held today which was<BR> commenced at 12:00 Noon and concluded at 03: 30 p.m. inter- alia has considered and approved the<BR> statement of un-audited financials result along with Limited Review Report for the quarter ended June<BR> 30, 2021.",
            "news_id": "622640ce-2b7d-41e6-92d6-5928a840ab25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28a3973c-08a6-4d68-a4d7-4aa71f904169.pdf",
            "news_date": "2021-08-16 10:34:43",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. August 14 , 2021",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations,<BR> 2015, we would like to inform you that the Board of Directors in their meeting held today which was<BR> commenced at 12:00 Noon and concluded at 03: 30 p.m. inter- alia has considered and approved the<BR> statement of un-audited financials result along with Limited Review Report for the quarter ended June<BR> 30, 2021.",
            "news_id": "8fbc5718-ad90-43a0-9f2d-61cd3ecda0ef",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45ebb828-3ef3-4c53-aaba-a50b75bc658d.pdf",
            "news_date": "2021-08-14 15:44:46",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Year Ended March 31, 2021",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 11:00 am and concluded at 01:30 p.m. inter- alia have considered and approved the following: <BR> 1. The Audited Financial Results of the Company for the Quarter and financial Year ended March 31, 2021.<BR> <BR> 2. Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year ended March 31, 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.<BR> A copy of the statement of audited Financial Results, Cash Flow statement along with Audited Report submitted by the Statutory Auditors of the Company is attached herewith. <BR>",
            "news_id": "c236f6fa-7f4d-4e26-ba27-f39427451e05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15f7718c-fc88-4df7-ba6d-43c789061941.pdf",
            "news_date": "2021-05-31 13:54:13",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. May 31, 2021",
            "news_body": "Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 11:00 am and concluded at 01:30 p.m. inter- alia have considered and approved the following: <BR> 1. The Audited Financial Results of the Company for the Quarter and financial Year ended March 31, 2021.<BR> <BR> 2. Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year ended March 31, 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.<BR>",
            "news_id": "0505ead3-6500-4659-8c3a-3961d1ae6538",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=861ed0be-74e7-4d51-8a3c-5dcd5d9f8108.pdf",
            "news_date": "2021-05-31 13:47:16",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LASA",
            "disp": "Lasa Supergenerics",
            "bse_code": 540702,
            "isin": "INE670X01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to our letter dated February 03, 2021 intimating you about the conference call with Analysts/Investors held on February 05, 2021, please find attached the transcript of the aforesaid conference call.",
            "news_id": "0db66688-94b9-45f1-9cb4-393bb55b20e1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4997609d-fb11-434e-b954-385d0a220530.pdf",
            "news_date": "2021-02-15 16:31:43",
            "seo": "lasa-supergenerics-ltd",
            "ltp": 8.99,
            "ch": 0.10999999999999943,
            "pch": 1.238738738738732,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 21713,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}